These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 18257437

  • 1. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
    van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2898-903. PubMed ID: 18257437
    [Abstract] [Full Text] [Related]

  • 2. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan 29; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 3. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 29; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 4. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun 29; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 29; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 6. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
    Heinrich M, Uder M.
    Rofo; 2007 Jun 29; 179(6):613-7. PubMed ID: 17497597
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr 29; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 8. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ, Kagan A, Chibnik LB, Kay J.
    Arthritis Rheum; 2007 Oct 29; 56(10):3433-41. PubMed ID: 17907148
    [Abstract] [Full Text] [Related]

  • 9. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep 29; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 10. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
    Andréjak M, Thuillier D, Lok C, Gras-Champel V.
    Therapie; 2007 Sep 29; 62(2):169-72. PubMed ID: 17582319
    [Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan 29; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Jan 29; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

  • 13. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D, Johnsen H, Juelsrud A, Løvhaug D.
    Acta Radiol; 2009 Mar 29; 50(2):156-69. PubMed ID: 19160079
    [Abstract] [Full Text] [Related]

  • 14. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.
    Clin Exp Dermatol; 2007 Jul 29; 32(4):353-8. PubMed ID: 17433041
    [Abstract] [Full Text] [Related]

  • 15. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E.
    Br J Dermatol; 2008 Mar 29; 158(3):607-10. PubMed ID: 18076707
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan 29; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb 29; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

  • 18. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May 29; 66(2):180-3. PubMed ID: 18342468
    [Abstract] [Full Text] [Related]

  • 19. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC, Yosipovitch G, Sheehan DJ, Sangüeza OP, Greenberg CS, Sane DC.
    Am J Dermatopathol; 2007 Oct 29; 29(5):433-6. PubMed ID: 17890909
    [Abstract] [Full Text] [Related]

  • 20. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.
    Hemodial Int; 2010 Jul 29; 14(3):289-94. PubMed ID: 20662951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.